China Chronic Kidney Disease (CKD) Market Report & Forecast 2021-2027

China Chronic Kidney Disease (CKD) Market Report & Forecast 2021-2027

Table of Contents
1 Introduction to Research & Analysis Reports
1.1 Chronic Kidney Disease (CKD) Market Definition
1.2 Market Segments
1.2.1 Segment by Type
1.2.2 Segment by Application
1.3 China Chronic Kidney Disease (CKD) Market Overview
1.4 Methodology & Sources of Information
1.4.1 Research Methodology
1.4.2 Research Process
1.4.3 Base Year
2 China Chronic Kidney Disease (CKD) Overall Market Size
2.1 China Chronic Kidney Disease (CKD) Market Size: 2021 VS 2027
2.2 China Chronic Kidney Disease (CKD) Revenue, Prospects & Forecasts: 2016-2027
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Chronic Kidney Disease (CKD) Players in China Market
3.2 Top China Chronic Kidney Disease (CKD) Companies Ranked by Revenue
3.3 China Chronic Kidney Disease (CKD) Revenue by Companies
3.4 Top 3 and Top 5 Chronic Kidney Disease (CKD) Companies in China Market, by Revenue in 2020
3.5 Companies Chronic Kidney Disease (CKD) Product Type
3.6 Tier 1, Tier 2 and Tier 3 Chronic Kidney Disease (CKD) Players in China Market
3.6.1 List of Tier 1 Chronic Kidney Disease (CKD) Companies in China
3.6.2 List of Tier 2 and Tier 3 Chronic Kidney Disease (CKD) Companies in China
4 Sights by Type
4.1 Overview
4.1.1 By Type - China Chronic Kidney Disease (CKD) Market Size Markets, 2021 & 2027
4.1.2 ACE Inhibitors
4.1.3 Calcium Channel Blockers
4.1.4 Beta Blockers
4.1.5 Others
4.2 By Type - China Chronic Kidney Disease (CKD) Revenue & Forecasts
4.2.1 By Type - China Chronic Kidney Disease (CKD) Revenue, 2016-2021
4.2.2 By Type - China Chronic Kidney Disease (CKD) Revenue, 2022-2027
4.2.3 By Type - China Chronic Kidney Disease (CKD) Revenue Market Share, 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - China Chronic Kidney Disease (CKD) Market Size, 2021 & 2027
5.1.2 Hospitals
5.1.3 Specialty Clinics
5.2 By Application - China Chronic Kidney Disease (CKD) Revenue & Forecasts
5.2.1 By Application - China Chronic Kidney Disease (CKD) Revenue, 2016-2021
5.2.2 By Application - China Chronic Kidney Disease (CKD) Revenue, 2022-2027
5.2.3 By Application - China Chronic Kidney Disease (CKD) Revenue Market Share, 2016-2027
6 Chronic Kidney Disease (CKD) Companies Profiles
6.1 AbbVie
6.1.1 AbbVie Company Details
6.1.2 AbbVie Business Overview
6.1.3 AbbVie Chronic Kidney Disease (CKD) Introduction
6.1.4 AbbVie Chronic Kidney Disease (CKD) Revenue in China Market (2016-2021)
6.1.5 AbbVie Recent Developments
6.2 Allergan
6.2.1 Allergan Company Details
6.2.2 Allergan Business Overview
6.2.3 Allergan Chronic Kidney Disease (CKD) Introduction
6.2.4 Allergan Chronic Kidney Disease (CKD) Revenue in China Market (2016-2021)
6.2.5 Allergan Recent Developments
6.3 Amgen
6.3.1 Amgen Company Details
6.3.2 Amgen Business Overview
6.3.3 Amgen Chronic Kidney Disease (CKD) Introduction
6.3.4 Amgen Chronic Kidney Disease (CKD) Revenue in China Market (2016-2021)
6.3.5 Amgen Recent Developments
6.4 AstraZeneca
6.4.1 AstraZeneca Company Details
6.4.2 AstraZeneca Business Overview
6.4.3 AstraZeneca Chronic Kidney Disease (CKD) Introduction
6.4.4 AstraZeneca Chronic Kidney Disease (CKD) Revenue in China Market (2016-2021)
6.4.5 AstraZeneca Recent Developments
6.5 Roche
6.5.1 Roche Company Details
6.5.2 Roche Business Overview
6.5.3 Roche Chronic Kidney Disease (CKD) Introduction
6.5.4 Roche Chronic Kidney Disease (CKD) Revenue in China Market (2016-2021)
6.5.5 Roche Recent Developments
6.6 FibroGen
6.6.1 FibroGen Company Details
6.6.2 FibroGen Business Overview
6.6.3 FibroGen Chronic Kidney Disease (CKD) Introduction
6.6.4 FibroGen Chronic Kidney Disease (CKD) Revenue in China Market (2016-2021)
6.6.5 FibroGen Recent Developments
6.7 GlaxoSmithKline
6.7.1 GlaxoSmithKline Company Details
6.7.2 GlaxoSmithKline Business Overview
6.7.3 GlaxoSmithKline Chronic Kidney Disease (CKD) Introduction
6.7.4 GlaxoSmithKline Chronic Kidney Disease (CKD) Revenue in China Market (2016-2021)
6.7.5 GlaxoSmithKline Recent Developments
6.8 Johnson & Johnson
6.8.1 Johnson & Johnson Company Details
6.8.2 Johnson & Johnson Business Overview
6.8.3 Johnson & Johnson Chronic Kidney Disease (CKD) Introduction
6.8.4 Johnson & Johnson Chronic Kidney Disease (CKD) Revenue in China Market (2016-2021)
6.8.5 Johnson & Johnson Recent Developments
6.9 Keryx
6.9.1 Keryx Company Details
6.9.2 Keryx Business Overview
6.9.3 Keryx Chronic Kidney Disease (CKD) Introduction
6.9.4 Keryx Chronic Kidney Disease (CKD) Revenue in China Market (2016-2021)
6.9.5 Keryx Recent Developments
6.10 Kissei
6.10.1 Kissei Company Details
6.10.2 Kissei Business Overview
6.10.3 Kissei Chronic Kidney Disease (CKD) Introduction
6.10.4 Kissei Chronic Kidney Disease (CKD) Revenue in China Market (2016-2021)
6.10.5 Kissei Recent Developments
6.11 Pfizer
6.11.1 Pfizer Company Details
6.11.2 Pfizer Business Overview
6.11.3 Pfizer Chronic Kidney Disease (CKD) Introduction
6.11.4 Pfizer Chronic Kidney Disease (CKD) Revenue in China Market (2016-2021)
6.11.5 Pfizer Recent Developments
6.12 Sanofi
6.12.1 Sanofi Company Details
6.12.2 Sanofi Business Overview
6.12.3 Sanofi Chronic Kidney Disease (CKD) Introduction
6.12.4 Sanofi Chronic Kidney Disease (CKD) Revenue in China Market (2016-2021)
6.12.5 Sanofi Recent Developments
6.13 Teva
6.13.1 Teva Company Details
6.13.2 Teva Business Overview
6.13.3 Teva Chronic Kidney Disease (CKD) Introduction
6.13.4 Teva Chronic Kidney Disease (CKD) Revenue in China Market (2016-2021)
6.13.5 Teva Recent Developments
7 Conclusion
8 Appendix
8.1 Note
8.2 Examples of Clients
8.3 Author Details
8.4 Disclaimer
List of Tables
Table 1. Chronic Kidney Disease (CKD) Market Opportunities & Trends in China Market
Table 2. Chronic Kidney Disease (CKD) Market Drivers in China Market
Table 3. Chronic Kidney Disease (CKD) Market Restraints in China Market
Table 4. Key Players of Chronic Kidney Disease (CKD) in China Market
Table 5. Top Chronic Kidney Disease (CKD) Players in China Market, Ranking by Revenue (2019)
Table 6. China Chronic Kidney Disease (CKD) Revenue by Companies, (US$, Mn), 2016-2021
Table 7. China Chronic Kidney Disease (CKD) Revenue Share by Companies, 2016-2021
Table 8. Companies Chronic Kidney Disease (CKD) Product Type
Table 9. List of Tier 1 Chronic Kidney Disease (CKD) Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Tier 2 and Tier 3 Chronic Kidney Disease (CKD) Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type - China Chronic Kidney Disease (CKD) Revenue, (US$, Mn), 2021 & 2027
Table 12. By Type - China Chronic Kidney Disease (CKD) Revenue (US$, Mn), 2016-2021
Table 13. By Type - China Chronic Kidney Disease (CKD) Revenue (US$, Mn), 2022-2027
Table 14. By Application - China Chronic Kidney Disease (CKD) Revenue, (US$, Mn), 2021 VS 2027
Table 15. By Application - China Chronic Kidney Disease (CKD) Revenue (US$, Mn), 2016-2021
Table 16. By Application - China Chronic Kidney Disease (CKD) Revenue (US$, Mn), 2022-2027
Table 17. AbbVie Company Details
Table 18. AbbVie Business Overview
Table 19. AbbVie Chronic Kidney Disease (CKD) Product
Table 20. AbbVie Chronic Kidney Disease (CKD) Revenue in China Market (2016-2021) & (US$ Million)
Table 21. AbbVie Recent Developments
Table 22. Allergan Company Details
Table 23. Allergan Business Overview
Table 24. Allergan Chronic Kidney Disease (CKD) Product
Table 25. Allergan Chronic Kidney Disease (CKD) Revenue in China Market (2016-2021) & (US$ Million)
Table 26. Allergan Recent Developments
Table 27. Amgen Company Details
Table 28. Amgen Business Overview
Table 29. Amgen Chronic Kidney Disease (CKD) Product
Table 30. Amgen Chronic Kidney Disease (CKD) Revenue in China Market (2016-2021) & (US$ Million)
Table 31. Amgen Recent Developments
Table 32. AstraZeneca Company Details
Table 33. AstraZeneca Business Overview
Table 34. AstraZeneca Chronic Kidney Disease (CKD) Product
Table 35. AstraZeneca Chronic Kidney Disease (CKD) Revenue in China Market (2016-2021) & (US$ Million)
Table 36. AstraZeneca Recent Developments
Table 37. Roche Company Details
Table 38. Roche Business Overview
Table 39. Roche Chronic Kidney Disease (CKD) Product
Table 40. Roche Chronic Kidney Disease (CKD) Revenue in China Market (2016-2021) & (US$ Million)
Table 41. Roche Recent Developments
Table 42. FibroGen Company Details
Table 43. FibroGen Business Overview
Table 44. FibroGen Chronic Kidney Disease (CKD) Product
Table 45. FibroGen Chronic Kidney Disease (CKD) Revenue in China Market (2016-2021) & (US$ Million)
Table 46. FibroGen Recent Developments
Table 47. GlaxoSmithKline Company Details
Table 48. GlaxoSmithKline Business Overview
Table 49. GlaxoSmithKline Chronic Kidney Disease (CKD) Product
Table 50. GlaxoSmithKline Chronic Kidney Disease (CKD) Revenue in China Market (2016-2021) & (US$ Million)
Table 51. GlaxoSmithKline Recent Developments
Table 52. Johnson & Johnson Company Details
Table 53. Johnson & Johnson Business Overview
Table 54. Johnson & Johnson Chronic Kidney Disease (CKD) Product
Table 55. Johnson & Johnson Chronic Kidney Disease (CKD) Revenue in China Market (2016-2021) & (US$ Million)
Table 56. Johnson & Johnson Recent Developments
Table 57. Keryx Company Details
Table 58. Keryx Business Overview
Table 59. Keryx Chronic Kidney Disease (CKD) Product
Table 60. Keryx Chronic Kidney Disease (CKD) Revenue in China Market (2016-2021) & (US$ Million)
Table 61. Keryx Recent Developments
Table 62. Kissei Company Details
Table 63. Kissei Business Overview
Table 64. Kissei Chronic Kidney Disease (CKD) Product
Table 65. Kissei Chronic Kidney Disease (CKD) Revenue in China Market (2016-2021) & (US$ Million)
Table 66. Kissei Recent Developments
Table 67. Pfizer Company Details
Table 68. Pfizer Business Overview
Table 69. Pfizer Chronic Kidney Disease (CKD) Product
Table 70. Pfizer Chronic Kidney Disease (CKD) Revenue in China Market (2016-2021) & (US$ Million)
Table 71. Pfizer Recent Developments
Table 72. Sanofi Company Details
Table 73. Sanofi Business Overview
Table 74. Sanofi Chronic Kidney Disease (CKD) Product
Table 75. Sanofi Chronic Kidney Disease (CKD) Revenue in China Market (2016-2021) & (US$ Million)
Table 76. Sanofi Recent Developments
Table 77. Teva Company Details
Table 78. Teva Business Overview
Table 79. Teva Chronic Kidney Disease (CKD) Product
Table 80. Teva Chronic Kidney Disease (CKD) Revenue in China Market (2016-2021) & (US$ Million)
Table 81. Teva Recent Developments
List of Figures
Figure 1. Chronic Kidney Disease (CKD) Segment by Type
Figure 2. Chronic Kidney Disease (CKD) Segment by Application
Figure 3. China Chronic Kidney Disease (CKD) Market Overview: 2020
Figure 4. China Chronic Kidney Disease (CKD) Market Size: 2021 VS 2027 (US$, Mn)
Figure 5. China Chronic Kidney Disease (CKD) Revenue, 2016-2027 (US$, Mn)
Figure 6. The Top 3 and 5 Players Market Share by Chronic Kidney Disease (CKD) Revenue in 2020
Figure 7. By Type - China Chronic Kidney Disease (CKD) Revenue Market Share, 2016-2027
Figure 8. By Application - China Chronic Kidney Disease (CKD) Revenue Market Share, 2016-2027
Figure 9. AbbVie Chronic Kidney Disease (CKD) Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 10. Allergan Chronic Kidney Disease (CKD) Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 11. Amgen Chronic Kidney Disease (CKD) Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 12. AstraZeneca Chronic Kidney Disease (CKD) Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 13. Roche Chronic Kidney Disease (CKD) Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 14. FibroGen Chronic Kidney Disease (CKD) Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 15. GlaxoSmithKline Chronic Kidney Disease (CKD) Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 16. Johnson & Johnson Chronic Kidney Disease (CKD) Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 17. Keryx Chronic Kidney Disease (CKD) Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 18. Kissei Chronic Kidney Disease (CKD) Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 19. Pfizer Chronic Kidney Disease (CKD) Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 20. Sanofi Chronic Kidney Disease (CKD) Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 21. Teva Chronic Kidney Disease (CKD) Revenue Year Over Year Growth (US$, Mn) & (2016-2021)

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Nuclear Medicine Cyclotron Systems Market Report, History and Forecast 2018-2029

Published: 11-Jan-2024        Price: US 3350 Onwards        Pages: 118

The global Nuclear Medicine Cyclotron Systems market was valued at US$ 220.85 million in 2022 and will reach US$ 283.75 million by the end of 2029, growing at a CAGR of 4.38% during 2023-2029. Asia-Pacific market for Nuclear Medicine Cyclotron Systems was valued at $ 61.16 million in 2022 and will reach $ 104.22 million by 2029, at a CAGR of 5.84% during the forecast period of 2023 through 2029. Report Scope This report aims to provide a comprehensive presentation of the glo......

Global Non-imaging Diagnostic Catheter Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 95

The global Non-imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Imaging Diagnostic Catheter Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 90

The global Imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated......

Global PCR Equipment Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 77

The global PCR Equipment market was valued at US$ 806 million in 2023 and is anticipated to reach US$ 1230.7 million by 2030, witnessing a CAGR of 6.7% during The forecast period 2024-2030. PCR (Polymerase Chain Reaction) equipment is widely used in molecular biology and genetics research for amplifying DNA and RNA sequences. The market for PCR equipment is influenced by several key drivers. Here are some of The significant market drivers: Advancements in Research and Diagnost......

Global Disposable Sterile Syringes and Needles Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 109

The global Disposable Sterile Syringes and Needles market was valued at US$ 404.4 million in 2023 and is anticipated to reach US$ 539.1 million by 2030, witnessing a CAGR of 2.1% during The forecast period 2024-2030. North American market for Disposable Sterile Syringes and Needles is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Disposable Sterile Syringes and N......

Global Orthopaedic Power Tools Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Orthopaedic Power Tools market was valued at US$ 463.3 million in 2023 and is anticipated to reach US$ 746.5 million by 2030, witnessing a CAGR of 7.3% during The forecast period 2024-2030. North American market for Orthopaedic Power Tools is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Orthopaedic Power Tools is estimated to increase from $ million i......

Global Cerebrospinal Fluid Management Devices Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Cerebrospinal Fluid Management Devices market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Cerebrospinal Fluid Management Devices is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Cerebrospinal Fluid Management Devices is estimate......

Global CAD & CAM Milling Burs Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 79

The global CAD & CAM Milling Burs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ ......

Global Artificial Teeth Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 98

The global Artificial Teeth market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, a......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs